Cohort Study to Evaluate Fetal and Infant Outcomes Following Maternal Exposure to Bimekizumab during Pregnancy

31/07/2026
03/09/2026
EU PAS number:
EUPAS1000001042
Study
Ongoing

ENCePP Code of conduct

No information provided.
Data sources
No information provided.
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Yes

Check completeness

Yes

Check stability

Unknown

Check logical consistency

Yes
Data characterisation

Data characterisation conducted

Yes
Procedures
No information provided.